These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 426874)

  • 41. [Liberation of platelet factor 4 during the platelet aggregation induced by ADP, thrombin and collagen fibres (author's transl)].
    Domingo-Albós A; Doménech-Mateu D; Castillo-Cofiño R
    Rev Esp Fisiol; 1973 Mar; 29(1):11-5. PubMed ID: 4749041
    [No Abstract]   [Full Text] [Related]  

  • 42. [Effect of heparin on platelet aggregation in vitro].
    Róka L; Isert D
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):735-49. PubMed ID: 6083949
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Platelet aggregation in platelet suspensions from Mongolian gerbils (Meriones unguiculatus).
    Agwu DE; Holub BJ; Johnstone IB; Crane S
    Can J Comp Med; 1983 Apr; 47(2):203-6. PubMed ID: 6883186
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bleeding disorders and acetylsalicylic acid ingestion. Clinical and biological repercussion in childhood].
    Blanco Quirós A; Valbuena C; Alvarez Guisasola FJ
    An Esp Pediatr; 1975; 8(1):48-57. PubMed ID: 1122082
    [No Abstract]   [Full Text] [Related]  

  • 45. The novel effect of a new prostacyclin analogue ZK36374 on the aggregation of human platelets in whole blood.
    Saniabadi AR; Lowe GD; Belch JJ; Forbes CD; Prentice CR; Barbenel JC
    Thromb Haemost; 1983 Oct; 50(3):718-21. PubMed ID: 6196854
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of proteoglycans (PG) and glycosaminoglycans (GAG) on ADP-, collagen- and thrombin-induced platelet aggregation.
    Klein K; Sinzinger H; Silberbauer K; Stachelberger H; Leithner C
    Artery; 1980; 8(5):410-5. PubMed ID: 6783013
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Behaviour of endogenous and newly absorbed serotonin in the platelet release reaction.
    Holmsen H; Ostvold AC; Day HJ
    Biochem Pharmacol; 1973 Oct; 22(20):2599-608. PubMed ID: 4763596
    [No Abstract]   [Full Text] [Related]  

  • 49. Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
    Sudo T; Ito H; Ozeki Y; Kimura Y
    Br J Pharmacol; 2001 Aug; 133(8):1396-404. PubMed ID: 11498527
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of PGI2 on platelet aggregation induced by various stimulants.
    Ohtsu A; Hoshina K; Kurozumi S; Hashimoto Y; Noguchi T; Nicolaou KC
    Nihon Ketsueki Gakkai Zasshi; 1979 Aug; 42(4):659-66. PubMed ID: 388963
    [No Abstract]   [Full Text] [Related]  

  • 51. The influence of benzamidine derivatives on human platelet function.
    Glusa E; Barthel W; Markwardt F
    Thromb Diath Haemorrh; 1974 Mar; 31(1):172-8. PubMed ID: 4365541
    [No Abstract]   [Full Text] [Related]  

  • 52. Studies on mammalian ribonucleotide reductase inhibition by pyridoxal phosphate and the dialdehyde derivatives of adenosine, adenosine 5'-monophosphate, and adenosine 5'-triphosphate.
    Cory JG; Mansell MM
    Cancer Res; 1975 Feb; 35(2):390-6. PubMed ID: 1109803
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pyridoxine increases nitric oxide biosynthesis in human platelets.
    Wu Y; Liu Y; Han Y; Cui B; Mi Q; Huang Y; Wang L; Jiang Q; Chen Q; Liu N; Ferro A; Ji Y
    Int J Vitam Nutr Res; 2009 Mar; 79(2):95-103. PubMed ID: 20108211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential effect of the antidiabetic thiazolidinediones troglitazone and pioglitazone on human platelet aggregation mechanism.
    Ishizuka T; Itaya S; Wada H; Ishizawa M; Kimura M; Kajita K; Kanoh Y; Miura A; Muto N; Yasuda K
    Diabetes; 1998 Sep; 47(9):1494-500. PubMed ID: 9726240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Visual micromethod for determining thrombocyte aggregation activity in the presence of different aggregating agents].
    Shitikova AS
    Lab Delo; 1984; (4):215-20. PubMed ID: 6202940
    [No Abstract]   [Full Text] [Related]  

  • 56. [Interrelationship between the dynamic function of thrombocytes and blood coagulation].
    Pastorova VE
    Usp Fiziol Nauk; 1977; 8(2):132-52. PubMed ID: 899185
    [No Abstract]   [Full Text] [Related]  

  • 57. Failure of certain antiplatelet drugs to affect myointimal thickening following arterial endothelial injury in the rat.
    Clowes AW; Karnovsky MJ
    Lab Invest; 1977 Apr; 36(4):452-64. PubMed ID: 846193
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 2,3-diphosphoglycerate: a physiological inhibitor of platelet aggregation.
    Iatridis SG; Iatridis PG; Markidou SG; Ragatz BH
    Science; 1975 Jan; 187(4173):259-61. PubMed ID: 1111100
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of platelet aggregation by drugs.
    Glusa E
    Acta Univ Carol Med Monogr; 1972; 52():83-6. PubMed ID: 4669829
    [No Abstract]   [Full Text] [Related]  

  • 60. [Thrombocyte aggregation in the cat].
    Hart S; Nolte I
    Tierarztl Prax; 1991 Aug; 19(4):413-8. PubMed ID: 1948990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.